Immediate Impact

1 by Nobel laureates 8 from Science/Nature 51 standout
Sub-graph 1 of 25

Citing Papers

Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults
2024 Standout
Opportunities and challenges in design and optimization of protein function
2024 Standout
2 intermediate papers

Works of April Killikelly being referenced

Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus
2016

Author Peers

Author Last Decade Papers Cites
April Killikelly 143 53 84 85 19 267
Mark Wurth 133 27 70 47 19 316
Nickita Mehta 103 28 116 97 14 318
Lunzhi Yuan 61 18 97 127 28 295
Subhradip Mukhopadhyay 90 26 73 65 17 314
J Kačaki 137 24 104 56 14 335
L. L. Waters 79 20 27 41 15 259
Isabel Pagani 84 12 48 175 22 314
Peiqi Yin 90 9 139 86 28 326
Alberto Zani 74 12 67 188 25 308
R. G. Shiva Manjunath 39 70 41 79 16 315

All Works

Loading papers...

Rankless by CCL
2026